Korro Bio, Inc.: 10% owner Lynx1 Capital Management bought 79,809 shares

What happened Lynx1 Capital Management LP (reported as a 10% owner) purchased a total of 79,809 shares of Korro Bio, Inc. on Oct 22, Oct 23 and Oct 26, 2026. The filing lists four purchases: 12,175 shares at $9.68 for $117,810; 40,000 shares at $11.04 for $441,464; 2,510 shares at $12.11 for $30,386; and 25,124 shares at $11.75 for $295,091. Total reported value of the purchases is $884,751.

Key details

• Transaction dates and prices: Oct 22, 2026 — 12,175 shares at $9.68 (weighted average; range $9.54–$9.8550) and 40,000 shares at $11.04 (weighted average; range $10.955–$11.11); Oct 23, 2026 — 2,510 shares at $12.11 (weighted average; range $11.9250–$12.3500); Oct 26, 2026 — 25,124 shares at $11.75 (weighted average; range $11.7450–$11.80).
• Shares owned after the transactions: not reported in this filing.
• Footnotes: the shares are held directly by Lynx1 Master Fund LP; Lynx1 Capital Management LP is the investment manager and Weston Nichols is sole member of the general partner. The reporting persons disclaim beneficial ownership except to the extent of any pecuniary interest. Weighted average prices reflect multiple transactions at the ranges noted above.
• Filing timeliness: not specified in the information provided.

Why it may matter

• The transactions are purchases (transaction code P), not option exercises, grants, sales or gifts.
• The reporting entity is a 10% owner (a large holder), not an individual company executive in this filing.
• A filing does not show why the insider traded or why the company acted.